Hyperfractionated radiotherapy with chemotherapy prolongs overall survival in head and neck squamous-cell carcinoma

Altered fractionation, specifically hyperfractionated radiotherapy, administered concomitantly with chemotherapy improved overall survival among patients with head and neck squamous-cell carcinoma, according to study published in The Lancet Oncology.
Cancer Therapy Advisor